The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

Costs varied across 5 European countries, driven primarily by repeated primary care visits and parental work absences.

So far, 1,046 cases have been reported from 31 jurisdictions, and 92% of the nation’s cases are part of outbreaks, which ...

An industry group responds, "Other than clean water, arguably nothing has done more to improve public health than vaccines." ...

Sequencing has revealed the clade 2 virus, which is fueling Sierra Leone's surge. So far 55 contacts have been identified in ...

The data show a continuation of a decades-old trend toward increasing US excess deaths, mainly among working-age adults, ...

Tularemia is spread via tick bites or through the skin, ingestion, or inhalation. In people, tularemia typically causes ...

A new model developed through the international Pediatric Emergency Research Network (PERN) creates a predictive tool that ...

The Food and Drug Administration (FDA) vaccine advisory group today recommended sticking with a monovalent JN.1 lineage ...

An experimental evaluation of the risk of influenza transmission from contaminated objects finds that viable virus was rarely ...

A comparative effectiveness study found patients treated with laLGPs had similar outcomes as those who received ...

The ARTIC 2.0 project will expand use of a low-cost, real-time genome sequencing technique used to detect COVID-19 variants ...